Insulin glargine

CHEBI:CHEBI_747260

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rxcui
1604544
package_marketing_start_date
22-JUN-23
active_ingredient_strength
300 U/mL
manufacturer_name
sanofi-aventis U.S. LLC
nui
M0011417
pharm_class_epc
Insulin Analog [EPC]
pharm_class
Insulin [CS]
pharm_class_cs
Insulin [CS]
brand_name_suffix
KwikPen
active_ingredient_name
INSULIN GLARGINE
package_description
1 BOX in 1 BOX (54568-766-10) / 30 BOX in 1 BOX / 330 CARTRIDGE in 1 BOX / 3 mL in 1 CARTRIDGE
unii
2ZM8CX04RZ
spl_set_id
257ca17b-6ff7-4f2e-9037-4c185bac5768
package_ndc
50090-6178-0
generic_name
insulin glargine
brand_name
Insulin glargine U-300 Max
brand_name_base
Insulin glargine U-300 Max
product_type
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
CRYSTAL
route
SUBCUTANEOUS
marketing_start_date
20090923
marketing_category
BULK INGREDIENT
labeler_name
sanofi-aventis U.S. LLC
product_ndc
54568-766
application_number
BLA021081
spl_id
4b3a97cd-8478-4619-bae6-121942de584a